Publications

Publications

Filter Results: (620) Arrow Down
Filter Results: (620) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 9 of 620 Results →
  • 18 May 2010
  • First Look

First Look: May 18

http://www.hbs.edu/research/pdf/10-095.pdf   Cases & Course MaterialsMonsanto: Helping Farmers Feed the World David E. Bell, Carin-Isabel Knoop, and Mary ShelmanHarvard Business School Case 510-025 Monsanto has led the effort to bring View Details
Keywords: Martha Lagace
  • Web

MS/MBA Biotechnology: Life Sciences | MBA

among many others. More About the MS/MBA Biotechnology: Life Sciences Program Play Bridging Science and Business: The MS/MBA Biotechnology Life Sciences Program video Play Video duration: 2:55 Curriculum Capstone Faculty & Advisors... View Details
  • Web

Faculty & Advisors | MBA

is a physician-scientist and life sciences entrepreneur currently serving as President and Head of Corporate Strategy and Business Development for Scorpion Therapeutics, an oncology-focused precision medicine biotechnology company. He... View Details
  • Web

Capstone | MBA

Capstone MS/MBA Biotechnology: Life Sciences Each student develops a capstone project in their second year of studies that challenges them to perform an in-depth structured scientific and business analysis of a biotechnology opportunity.... View Details
  • March 2020
  • Article

Organizing Knowledge Production Teams Within Firms for Innovation

By: Vikas A. Aggarwal, David H. Hsu and Andy Wu
How should firms organize their pool of inventive human capital for firm-level innovation? While access to diverse knowledge may aid knowledge recombination, which can facilitate innovation, prior literature has focused primarily on one way of achieving that: diversity... View Details
Keywords: Knowledge Recombination; Organization Design; Team Boundary; Innovation; Knowledge Sharing; Diversity; Innovation and Invention; Groups and Teams; Human Capital; Organizational Design
Related
  • May 2016
  • Case

AbbVie

By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
Keywords: Pharmaceutical Company; M＆A Valuation; AbbVie; Health Care; Health Care and Treatment; Pharmaceutical Industry; Health Industry; United States
Related
  • Article

Extending the Role of Headquarters Beyond the Firm Boundary: Entrepreneurial Alliance Innovation

By: Jaeho Kim and Andy Wu
Prior research on corporate headquarters (CHQ) characteristics identifies the impact of CHQ location and composition on the innovation outcomes of internal subsidiaries. However, given that external strategic alliances with high-tech entrepreneurial firms represent a... View Details
Keywords: Alliance; Innovation; Corporate Headquarters; Geographic Proximity; Entrepreneurship; Corporate Strategy; Alliances; Joint Ventures; Innovation and Invention; Business Headquarters; Geographic Location
Related
  • Web

Admissions & Financial Aid | MBA

Admissions & Financial Aid MS/MBA Biotechnology: Life Sciences The program seeks a diverse group of outstanding students who have an undergraduate degree in life sciences and/or significant workplace experience in biotechnology or life... View Details

    Ray A. Goldberg

    A native of North Dakota, Dr. Goldberg received his A.B. from Harvard University in 1948, his MBA from the Harvard Graduate School of Business Administration in 1950 and his Ph.D. in Agricultural Economics from the University of Minnesota in 1952.

    ... View Details

    Keywords: agribusiness; agriculture; fast food; food; food processing; forest products; grocery; high technology; information; restaurant; retailing; soft drink; textiles; tobacco; transportation; wholesale; wine
    • 2010
    • Working Paper

    Venture Capital Investment in the Clean Energy Sector

    By: Shikhar Ghosh and Ramana Nanda
    We examine the extent to which venture capital is adequately positioned for the rapid commercialization of clean energy technologies in the United States. While there are several startups in clean energy that are well-suited to the traditional venture capital... View Details
    Keywords: Business Startups; Energy Generation; Venture Capital; Investment; Governing Rules, Regulations, and Reforms; Technological Innovation; Competition; Energy Industry; Green Technology Industry; United States
    Related
    • March 2016
    • Article

    Environmental Demands and the Emergence of Social Structure: Technological Dynamism and Interorganizational Network Forms

    By: Adam Tatarynowicz, Maxim Sytch and Ranjay Gulati
    This study investigates the origins of variation in the structures of interorganizational networks across industries. We combine empirical analyses of existing interorganizational networks in six industries with an agent-based simulation model of network emergence.... View Details
    Keywords: Interorganizatonal Relationships; Social Networks; Network Emergence; Interorganizational Networks; Information Technology; Networks; Organizational Structure; Social and Collaborative Networks; Social Media
    Related
    • September 2020
    • Case

    Minerva 2004: Discovery

    By: John R. Wells and Benjamin Weinstock
    After nearly five years in operation, Doctor Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Corporation (Minerva), was reflecting on the company’s next steps. In a few short years, she and her small team had managed to develop a nanoparticle process for... View Details
    Keywords: Entrepreneurship; Financing and Loans; Strategy; Decision Choices and Conditions; Biotechnology Industry
    Related

      Michael E. Porter

      Michael Porter is an economist, researcher, author, advisor, speaker and teacher. Throughout his career at Harvard Business School, he has brought economic theory and strategy concepts to bear on many of the most challenging problems facing corporations, economies... View Details

      Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology

        Karim R. Lakhani

        Karim R. Lakhani is the Dorothy & Michael Hintze Professor of Business Administration at the Harvard Business School. He specializes in technology management, innovation, digital transformation and artificial... View Details

        Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
        • Web

        Blavatnik Fellowship in Life Science Entrepreneurship - Health Care

        CEO of KiraGen Bio, a biotech company that utilizes machine learning-driven multiplex gene editing to engineer CAR-T cells that can resist the immunosuppressive effects of solid tumor microenvironments. With extensive experience in the View Details

          Rembrand M. Koning

          Rem Koning is the Mary V. and Mark A. Stevens Associate Professor at Harvard Business School. He researches and teaches entrepreneurship, exploring the biases and frictions that shape how founders and markets learn. His current research explores... View Details

          Keywords: biotechnology; biotechnology; biotechnology
          • 25 Mar 2016
          • HBS Seminar

          Curtis Keith, Harvard University, Blavatnik Biomedical Accelerator

            Josh Lerner

            Josh Lerner graduated from Yale College with a special divisional major. He worked for several years on issues concerning technological innovation and public policy at the Brookings Institution, for a public-private task force in Chicago, and on... View Details

            Keywords: biotechnology; biotechnology; biotechnology

              Andy Wu

              Andy Wu is the Arjun and Minoo Melwani Family Associate Professor of Business Administration in the Strategy Unit at Harvard Business School, where he teaches in the MBA and Executive Education programs. He researches, teaches, and advises managers... View Details

              Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology

                Srikant M. Datar

                Srikant M. Datar became the eleventh dean of Harvard Business School on 1 January 2021. During his tenure as a faculty member, he served as Senior Associate Dean for University Affairs (including Faculty Chair of the Harvard Innovation Lab), for Research, for... View Details

                Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology